Evidence map›Paper›PMID 24855561›Full record

ArticleMicrobiome2014

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation.

Vijay Shankar, Matthew J Hamilton, Alexander Khoruts, Amanda Kilburn, Tatsuya Unno, Oleg Paliy, Michael J Sadowsky

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Microbiome, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02318134 (Fecal Microbiota Transplantation in SAP(Severe Acute Pancreatitis)Patients With Intestinal Barrier Dysfunction), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02318134 phase2completednot on this mapstarted 2017, after this paper: background citation

Fecal Microbiota Transplantation in SAP(Severe Acute Pancreatitis)Patients With Intestinal Barrier Dysfunction

TypeinterventionalSponsorThe First Affiliated Hospital of Nanchang UniversityRan2017 to 2019Enrolled60ConditionsAcute Pancreatitis, Intestinal Bacteria Flora Disturbance, Intestinal Dysfunction, Fecal Microbiota TransplantationArmsFecal Microbiota Transplantation, normal saline
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Avoiding Premature Antibiotic Use in RecurrentACG case reports journal · 2025
    Article
  6. Article
  7. Pathogens (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Gut Microbiota andInternational journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Application of Microbiome Management in Therapy forPathogens (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Review
  15. The contribution of bile acid metabolism to the pathogenesis ofTherapeutic advances in gastroenterology · 2021
    Review
  16. Review
  17. Defined microbiota transplant restores Th17/RORγtProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Fecal Transplant in Children WithOpen forum infectious diseases · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vijay ShankarDepartment of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, 3640 Col. Glenn Hwy, Dayton, OH 45435, USA.
Matthew J HamiltonDepartment of Soil, Water, and Climate, Biotechnology Institute, and Microbial Plant and Genomics Institute, University of Minnesota, 140 Gortner Lab, 1479 Gortner Avenue, St. Paul, MN 55108, USA.
Alexander KhorutsDivision of Gastroenterology; Department of Medicine, Center for Immunology, University of Minnesota, Minneapolis, MN USA.
Amanda KilburnDepartment of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, 3640 Col. Glenn Hwy, Dayton, OH 45435, USA.
Tatsuya UnnoDepartment of Soil, Water, and Climate, Biotechnology Institute, and Microbial Plant and Genomics Institute, University of Minnesota, 140 Gortner Lab, 1479 Gortner Avenue, St. Paul, MN 55108, USA.
Oleg PaliyDepartment of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, 3640 Col. Glenn Hwy, Dayton, OH 45435, USA.
Michael J SadowskyDepartment of Soil, Water, and Climate, Biotechnology Institute, and Microbial Plant and Genomics Institute, University of Minnesota, 140 Gortner Lab, 1479 Gortner Avenue, St. Paul, MN 55108, USA.
Wright State University · USBiotechnology Institute · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClostridium difficile is an opportunistic human intestinal pathogen, and C. difficile infection (CDI) is one of the main causes of antibiotic-induced diarrhea and colitis. One successful approach to combat CDI, particularly recurrent form of CDI, is through transplantation of fecal microbiota from a healthy donor to the infected patient. In this study we investigated the distal gut microbial communities of three CDI patients before and after fecal microbiota transplantation, and we compared these communities to the composition of the donor's fecal microbiota. We utilized phylogenetic Microbiota Array, high-throughput Illumina sequencing, and fluorescent in situ hybridization to profile microbiota composition down to the genus and species level resolution.

resultsThe original patients' microbiota had low diversity, was dominated by members of Gammaproteobacteria and Bacilli, and had low numbers of Clostridia and Bacteroidia. At the genus level, fecal samples of CDI patients were rich in members of the Lactobacillus, Streptococcus, and Enterobacter genera. In comparison, the donor community was dominated by Clostridia and had significantly higher diversity and evenness. The patients' distal gut communities were completely transformed within 3 days following fecal transplantation, and these communities remained stable in each patient for at least 4 months. Despite compositional differences among recipients' pre-treatment gut microbiota, the transplanted gut communities were highly similar among recipients post-transplantation, were indistinguishable from that of the donor, and were rich in members of Blautia, Coprococcus, and Faecalibacterium. In each case, the gut microbiota restoration led to a complete patient recovery and symptom alleviation.

conclusionWe conclude that C. difficile infection can be successfully treated by fecal microbiota transplantation and that this leads to stable transformation of the distal gut microbial community from the one abundant in aerotolerant species to that dominated by members of the Clostridia.

Indexed as

Clostridium difficileFecal microbiota transplantationMicrobiotaMicrobiota ArrayMicroflora

Identifiers

PMID24855561
PMCPMC4030581
OpenAlexW2156875941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.